Filing Details

Accession Number:
0001628280-24-000698
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-05 17:33:36
Reporting Period:
2024-01-03
Accepted Time:
2024-01-05 17:33:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1104506 Insmed Inc INSM Pharmaceutical Preparations (2834) 541972729
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1930805 Drayton John Wise 700 Us Highway 202/206
Bridgewater NJ 08807
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Stock Option (Right To Buy) Acquisiton 2024-01-03 20,071 $19.11 124,055 No 4 M Direct
Stock Option (Right To Buy) Disposition 2024-01-03 20,071 $29.19 103,984 No 4 S Direct
Common Stock Acquisiton 2024-01-04 12,873 $0.00 116,857 No 4 A Direct
Common Stock Disposition 2024-01-05 1,167 $29.32 115,690 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-01-03 20,071 $0.00 20,071 $19.11
Common Stock Stock Option (right to buy) Acquisiton 2024-01-04 63,560 $0.00 63,560 $29.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-02-10 No 4 M Direct
63,560 2034-01-04 No 4 A Direct
Footnotes
  1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. Includes 1,303 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
  3. This is the weighted average sales price representing 20,071 shares sold at prices ranging from $28.915 to $29.39 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.
  5. Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration.
  6. Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
  7. Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.
  8. Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.